Terry Kelly

Terry has over 10 years of experience in Epigenetics including developing novel technologies and seeing them through to commercialization. She previously was the R&D Director at Active Motif and the Global leader for custom assays and services and Agena Bioscience. She received her PhD from UCLA and did Post-doctoral training at USC’s Norris Cancer Center where she studied epigenetic regulation in cancer.